120 related articles for article (PubMed ID: 16325717)
1. Apraclonidine and LASIK.
Aslanides IM; Tsiklis NS; Pallikaris IG; Jankov MR; Coskunseven E; Ozkilic E
Ophthalmology; 2005 Dec; 112(12):2238; author reply 2244. PubMed ID: 16325717
[No Abstract] [Full Text] [Related]
2. Early flap dislocation with perioperative brimonidine use in laser in situ keratomileusis.
Nowroozzadeh MH
J Cataract Refract Surg; 2010 Feb; 36(2):368. PubMed ID: 20152647
[No Abstract] [Full Text] [Related]
3. The effect of topical apraclonidine on subconjunctival hemorrhage and flap adherence in LASIK patients.
Aslanides lM; Tsiklis NS; Ozkilic E; Coskunseven E; Pallikaris lG; Jankov MR
J Refract Surg; 2006 Jun; 22(6):585-8. PubMed ID: 16805122
[TBL] [Abstract][Full Text] [Related]
4. Effect of prophylactic brimonidine on bleeding complications and flap adherence after laser in situ keratomileusis.
Norden RA
J Refract Surg; 2002; 18(4):468-71. PubMed ID: 12160159
[TBL] [Abstract][Full Text] [Related]
5. Topical phenylephrine in laser in situ keratomileusis.
Issa AF
J Cataract Refract Surg; 2007 Feb; 33(2):355-6. PubMed ID: 17276291
[No Abstract] [Full Text] [Related]
6. Effect of prophylactic topical brimonidine (0.15%) administration on the development of subconjunctival hemorrhage after intravitreal injection.
Kim CS; Nam KY; Kim JY
Retina; 2011 Feb; 31(2):389-92. PubMed ID: 20890238
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of cyclosporine 0.05% drops versus unpreserved artificial tears in dry-eye patients having laser in situ keratomileusis.
Salib GM; McDonald MB; Smolek M
J Cataract Refract Surg; 2006 May; 32(5):772-8. PubMed ID: 16765793
[TBL] [Abstract][Full Text] [Related]
8. Reduction of anterior-segment vascularity with preoperative topical apraclonidine 1%.
Sii F; Todd B; Shah P; Chiang M
J Cataract Refract Surg; 2006 Apr; 32(4):692-3. PubMed ID: 16698500
[No Abstract] [Full Text] [Related]
9. Comparison of Epi-LASIK and off-flap Epi-LASIK for the treatment of low and moderate myopia.
Kalyvianaki MI; Kymionis GD; Kounis GA; Panagopoulou SI; Grentzelos MA; Pallikaris IG
Ophthalmology; 2008 Dec; 115(12):2174-80. PubMed ID: 19041475
[TBL] [Abstract][Full Text] [Related]
10. More than just an ocular solution.
Pekdemir M; Yanturali S; Karakus G
Emerg Med J; 2005 Oct; 22(10):753-4. PubMed ID: 16189050
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic brimonidine before LASIK.
Uretmen O; Ates H; Andaç K
J Refract Surg; 2003; 19(5):612. PubMed ID: 14518756
[No Abstract] [Full Text] [Related]
12. Brinzolamide 1% versus apraclonidine 0.5% to prevent intraocular pressure elevation after neodymium:YAG laser posterior capsulotomy.
Unal M; Yücel I; Akar Y
J Cataract Refract Surg; 2006 Sep; 32(9):1499-502. PubMed ID: 16931262
[TBL] [Abstract][Full Text] [Related]
13. Effect of apraclonidine versus dorzolamide on intraocular pressure after phacoemulsification.
Onal S; Gozum N; Gucukoglu A
Ophthalmic Surg Lasers Imaging; 2005; 36(6):457-62. PubMed ID: 16355950
[TBL] [Abstract][Full Text] [Related]
14. Effect of prophylactic brimonidine instillation on bleeding during strabismus surgery in adults.
Hong S; Kim CY; Seong GJ; Han SH
Am J Ophthalmol; 2007 Sep; 144(3):469-70. PubMed ID: 17765438
[TBL] [Abstract][Full Text] [Related]
15. Use of 0.5% apraclonidine solution in evaluation of blepharoptosis.
Yazici B; Beden U
Ophthalmic Plast Reconstr Surg; 2008; 24(4):299-301. PubMed ID: 18645436
[TBL] [Abstract][Full Text] [Related]
16. Subconjuctival hemorrhages after LASIK. Laser in situ keratomileusis.
Dada T; Sharma N; Vaypayee RB; Dada VK
J Cataract Refract Surg; 2000 Nov; 26(11):1570-1. PubMed ID: 11185595
[No Abstract] [Full Text] [Related]
17. Exposure to topical apraclonidine in children with glaucoma.
Wright TM; Freedman SF
J Glaucoma; 2009; 18(5):395-8. PubMed ID: 19525731
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of brimonidine tartrate 0.2% ophthalmic solution in reducing halos after laser in situ keratomileusis.
Lee JH; You YS; Choe CM; Lee ES
J Cataract Refract Surg; 2008 Jun; 34(6):963-7. PubMed ID: 18499002
[TBL] [Abstract][Full Text] [Related]
19. The incidence and risk factors for developing dry eye after myopic LASIK.
De Paiva CS; Chen Z; Koch DD; Hamill MB; Manuel FK; Hassan SS; Wilhelmus KR; Pflugfelder SC
Am J Ophthalmol; 2006 Mar; 141(3):438-45. PubMed ID: 16490488
[TBL] [Abstract][Full Text] [Related]
20. Laser in situ keratomileusis versus surface ablation: visual outcomes and complications.
Ghadhfan F; Al-Rajhi A; Wagoner MD
J Cataract Refract Surg; 2007 Dec; 33(12):2041-8. PubMed ID: 18053901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
